178 related articles for article (PubMed ID: 6287782)
1. Growth hormone, prolactin and cortisol nyctohemeral variations during naloxone-induced opiate receptor blockade in man.
Delitala G; Giusti M; Rodriguez G; Mazzocchi G; Ferrini S; Baccelliere L; Montano V; Rosadini G; Giordano G
Acta Endocrinol (Copenh); 1982 Jul; 100(3):321-6. PubMed ID: 6287782
[TBL] [Abstract][Full Text] [Related]
2. Effects of naloxone on prolactin, growth hormone and cortisol response to insulin hypoglycemia in obese subjects.
Papalia D; Lunetta M; Di Mauro M
J Endocrinol Invest; 1989 Dec; 12(11):777-82. PubMed ID: 2693516
[TBL] [Abstract][Full Text] [Related]
3. Opioid modulation of the effects of repeated stress on ACTH, cortisol, prolactin, and growth hormone in pigs.
Rushen J; Schwarze N; Ladewig J; Foxcroft G
Physiol Behav; 1993 May; 53(5):923-8. PubMed ID: 8390062
[TBL] [Abstract][Full Text] [Related]
4. Failure of naloxone to influence plasma growth hormone, prolactin, and cortisol secretions induced by insulin hypoglycemia.
Wakabayashi I; Demura R; Miki N; Ohmura E; Miyoshi H; Shizume K
J Clin Endocrinol Metab; 1980 Mar; 50(3):597-9. PubMed ID: 6987258
[TBL] [Abstract][Full Text] [Related]
5. Opiate receptors and anterior pituitary hormone secretion in man. Effect of naloxone infusion.
Delitala G; Devilla L; Arata L
Acta Endocrinol (Copenh); 1981 Jun; 97(2):150-6. PubMed ID: 6263025
[TBL] [Abstract][Full Text] [Related]
6. The role of opiate, dopaminergic, and adrenergic systems in the hypothalamo-pituitary dysfunction in obesity.
Baranowska B; Singh SP; Soszynski P; Nowakowski J; Jeske W
Acta Endocrinol (Copenh); 1987 Oct; 116(2):221-8. PubMed ID: 2889310
[TBL] [Abstract][Full Text] [Related]
7. Hormone response to repeated electroconvulsive therapy: effects of naloxone.
Haskett RF; Zis AP; Albala AA
Biol Psychiatry; 1985 Jun; 20(6):623-33. PubMed ID: 2986737
[TBL] [Abstract][Full Text] [Related]
8. Oxytocin reduces exercise-induced ACTH and cortisol rise in man.
Coiro V; Passeri M; Davoli C; Bacchi-Modena A; Bianconi L; Volpi R; Chiodera P
Acta Endocrinol (Copenh); 1988 Nov; 119(3):405-12. PubMed ID: 2847472
[TBL] [Abstract][Full Text] [Related]
9. The effect of an opiate antagonist on the hormonal changes induced by hexarelin.
Korbonits M; Trainer PJ; Besser GM
Clin Endocrinol (Oxf); 1995 Sep; 43(3):365-71. PubMed ID: 7586608
[TBL] [Abstract][Full Text] [Related]
10. Lack of modulation of pituitary hormone stress response by neural pathways involving opiate receptors.
Spiler IJ; Molitch ME
J Clin Endocrinol Metab; 1980 Mar; 50(3):516-20. PubMed ID: 6244322
[TBL] [Abstract][Full Text] [Related]
11. Opiate receptor blockade and diurnal pituitary and adrenal hormone levels.
Leslie RD; Prescott RW; Kendall-Taylor P; Cook D; Weightman D; Ratcliffe J; Ingram MC
Horm Metab Res; 1985 Feb; 17(2):86-9. PubMed ID: 2985486
[TBL] [Abstract][Full Text] [Related]
12. Stress and nursing in the pig: role of HPA axis and endogenous opioid peptides.
Rushen J; Nay TS; Wright LR; Payne DC; Foxcroft GR
Physiol Behav; 1995 Jul; 58(1):43-8. PubMed ID: 7667426
[TBL] [Abstract][Full Text] [Related]
13. Naloxone has no effect on hormonal responses to ECT in man.
Turner TH; Ur E; Grossman A
Psychiatry Res; 1987 Nov; 22(3):207-12. PubMed ID: 2829259
[TBL] [Abstract][Full Text] [Related]
14. Serum prolactin and growth hormone responses to naloxone and intracerebral ventricle morphine administration in heifers.
Leshin LS; Rund LA; Thompson FN; Mahaffey MB; Chang WJ; Byerley DJ; Kiser TE
J Anim Sci; 1990 Jun; 68(6):1656-65. PubMed ID: 2384365
[TBL] [Abstract][Full Text] [Related]
15. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
[TBL] [Abstract][Full Text] [Related]
16. Endocrine actions of opioids.
Pfeiffer A; Herz A
Horm Metab Res; 1984 Aug; 16(8):386-97. PubMed ID: 6088380
[TBL] [Abstract][Full Text] [Related]
17. Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers.
Naber D; Pickar D; Davis GC; Cohen RM; Jimerson DC; Elchisak MA; Defraites EG; Kalin NH; Risch SC; Buchsbaum MS
Psychopharmacology (Berl); 1981; 74(2):125-8. PubMed ID: 6267643
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous study of cortisol, growth hormone and prolactin nyctohemeral variations in normal and obese subjects. Influence of prolonged fasting in obesity.
Copinschi G; De Laet MH; Brion JP; Leclercq R; L'Hermite M; Robyn C; Virasoro E; Van Cauter E
Clin Endocrinol (Oxf); 1978 Jul; 9(1):15-26. PubMed ID: 679499
[TBL] [Abstract][Full Text] [Related]
19. Naloxone antagonism of corticotropin-releasing hormone stimulation of prolactin secretion in rhesus monkeys.
Vanvugt DA; Webb MY; Reid RL
J Clin Endocrinol Metab; 1989 Jun; 68(6):1060-6. PubMed ID: 2542355
[TBL] [Abstract][Full Text] [Related]
20. Partial blockade by naloxone of clonidine-induced increase in plasma growth hormone in hypertensive patients.
Bramnert M; Hökfelt B
J Clin Endocrinol Metab; 1984 Feb; 58(2):374-7. PubMed ID: 6319449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
